CD Diagnostics, Inc.

WYNNEWOOD, PA · Founded 2011 · Medtech · Acquired

Synovasure®, a diagnostic test for joint pain that analyzes synovial fluid

Claim this profile

Follows are private to you and power your alerts

Updated · cddiagnostics.com

Sector
Medtech
Headquarters
WYNNEWOOD, PA
Founded
2011
Latest Form D
$2.8M, Jun 2012
Total capital
$2.8M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$2.8M
2 Form D · last Jun 2012
172 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
5
12 pending · first 2018
Rank in peer group#26 of 160

Capital timeline

2012FEDERAL ↑EQUITY ↓Cumulative $2.8M1st Form D$2.8M
2012FEDERAL ↑EQUITY ↓Cumulative $2.8M1st Form D$2.8M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$2.8M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

1 record has no date or no amount, so it isn’t placed on the timeline.

Standing among 160 peers

Line = median

Medtech · Instrument

  • Granted patents#26 · top 16%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Carl C. DeirmengianResearcherDirectorLinked by 3 patents
  • Daniel R. GennettDirectorNamed in SEC Form D filings
  • David F. PfeifferDirectorNamed in SEC Form D filings
  • Michael J. BehrExecutive Officer, DirectorNamed in SEC Form D filings
  • Richard C. BirkmeyerExecutive Officer, DirectorNamed in SEC Form D filings
  • Richard P. SchwartzDirectorNamed in SEC Form D filings
Show all 9 people
  • Richard P. SchwarzDirectorNamed in SEC Form D filings
  • Robert E. BoothDirectorNamed in SEC Form D filings
  • Robert E. Booth, Jr.DirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 17
Show all 17 patent records
  • Biomarkers Of Early OsteoarthritisJun 16, 2026 · US 12,656,343Granted
  • System For Detecting Infection In Synovial FluidNov 6, 2025 · Application 19268358Pending
  • System For Detecting Infection In Synovial FluidAug 12, 2025 · US 12,385,909Granted
  • Methods And Techniques For Diagnosing InfectionsFeb 27, 2025 · Application 18813597Pending
  • Combination Of Host Response And Direct Antigen Detection For Detection Of Infection Caused By Fastidious OrganismsDec 5, 2024 · Application 18679174Pending
  • System For Detecting Infection In Synovial FluidNov 15, 2022 · US 11,499,970Granted
  • Pre-surgical Diagnostic Tool Using Biomarkers To Evaluate The Risk Factors Of Post Surgical ComplicationsMay 5, 2022 · Application 17573843Pending
  • Aqueous Citrate-buffered Metal SolutionsSep 14, 2021 · US 11,119,094Granted
  • Diagnostic Assay For Source Of InflammationAug 13, 2020 · Application 16864575Pending
  • System For Detecting Infection In Synovial FluidNov 27, 2018 · US 10,139,405Granted
  • Direct Detection Of Microorganisms In Patient Samples By ImmunoassayMay 10, 2018 · Application 15803420Pending
  • Methods For Detecting Adverse Local Tissue Reaction (altr) NecrosisFeb 15, 2018 · Application 15664402Pending
  • System For Detecting Infection In Synovial FluidApplication PCTUS2012061350Pending
  • Direct Detection Of Microorganisms In Patient Samples By ImmunoassayApplication PCTUS2017059966Pending
  • Methods For Detecting Adverse Local Tissue Reaction (altr) NecrosisApplication PCTUS2016045158Pending
  • Methods For Detecting Adverse Local Tissue Reaction (altr) NecrosisApplication 62200885Pending
  • Biomarkers Of Early OsteoarthritisApplication PCTUS2020057967Pending
  • OrisDx Inc.Similar federal contract value in Medtech · null in contracts
  • BRIO DEVICE, LLCSimilar federal contract value in Medtech · null in contracts
  • XanderGlasses, Inc.Similar federal contract value in Medtech · null in contracts
  • ENTVANTAGE DIAGNOSTICS, INCSimilar federal contract value in Medtech · null in contracts
  • AOA DX Inc.Similar federal contract value in Medtech · null in contracts
  • POSITRON CORPSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .